Surgery Following EGFR TKI Therapy Shows Potential to Extend Progression-Free Survival in Metastatic NSCLC
(Barcelona, Spain, September 9, 2025, 10:15 a.m. CEST / UTC +2) — Groundbreaking findings from a randomized Phase II clinical ...
(Barcelona, Spain, September 9, 2025, 10:15 a.m. CEST / UTC +2) — Groundbreaking findings from a randomized Phase II clinical ...
In recent years, the landscape of lung cancer diagnosis and screening has witnessed a significant paradigm shift, particularly in recognizing ...
In a significant development in the field of thoracic oncology, recent findings from the Phase 3 E4512 clinical trial have ...
In a groundbreaking development presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine